A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Capital Rx to Acquire Healthcare Navigation Platform Amino HealthHealthradar14. Juni 2025 What You Should Know: – Capital Rx, Inc., the enterprise health technology company announced the acquisition of Amino Health and…
Health Seae Ventures acquires Unseen Capital after founder deathHealthradar1. Juni 2025 Seae Ventures is acquiring Unseen Capital after the death of founder Kayode Owens in 2021. The combined firm will continue…
